Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and Growth Factors for MDS
NCT00398047Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in myelodysplastic syndrome (MDS), sponsored by Wake Forest University Health Sciences. Started Sep 2006; status: terminated.
02
Drugs
azacitidine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00398047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398047.